Homestead Advisers Corp Has $5.23 Million Stock Position in Plexus Corp. (NASDAQ:PLXS)

Homestead Advisers Corp increased its stake in shares of Plexus Corp. (NASDAQ:PLXS - Free Report) by 14.6% during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 40,800 shares of the technology company's stock after buying an additional 5,200 shares during the period. Homestead Advisers Corp owned 0.15% of Plexus worth $5,228,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in PLXS. American Century Companies Inc. increased its stake in shares of Plexus by 72.2% in the 4th quarter. American Century Companies Inc. now owns 544,017 shares of the technology company's stock valued at $85,128,000 after acquiring an additional 228,027 shares during the last quarter. Nuveen Asset Management LLC increased its stake in shares of Plexus by 6.6% in the 4th quarter. Nuveen Asset Management LLC now owns 351,557 shares of the technology company's stock valued at $55,012,000 after acquiring an additional 21,911 shares during the last quarter. Northern Trust Corp grew its position in shares of Plexus by 10.0% in the 4th quarter. Northern Trust Corp now owns 332,100 shares of the technology company's stock valued at $51,967,000 after purchasing an additional 30,163 shares during the period. JPMorgan Chase & Co. grew its position in shares of Plexus by 146.9% in the 4th quarter. JPMorgan Chase & Co. now owns 258,824 shares of the technology company's stock valued at $40,501,000 after purchasing an additional 154,003 shares during the period. Finally, Victory Capital Management Inc. grew its position in shares of Plexus by 8.3% in the 1st quarter. Victory Capital Management Inc. now owns 185,200 shares of the technology company's stock valued at $23,730,000 after purchasing an additional 14,267 shares during the period. 94.45% of the stock is owned by institutional investors.

Plexus Stock Performance

Shares of PLXS traded down $1.35 during midday trading on Tuesday, reaching $134.21. 31,268 shares of the stock were exchanged, compared to its average volume of 171,227. Plexus Corp. has a twelve month low of $103.43 and a twelve month high of $172.89. The company has a quick ratio of 0.71, a current ratio of 1.53 and a debt-to-equity ratio of 0.07. The company has a market cap of $3.64 billion, a P/E ratio of 26.14 and a beta of 0.80. The stock's 50 day simple moving average is $133.63 and its 200 day simple moving average is $134.47.

Plexus (NASDAQ:PLXS - Get Free Report) last posted its earnings results on Wednesday, April 23rd. The technology company reported $1.66 earnings per share for the quarter, topping analysts' consensus estimates of $1.54 by $0.12. Plexus had a return on equity of 11.17% and a net margin of 3.60%. The company had revenue of $980.17 million during the quarter, compared to the consensus estimate of $980.07 million. During the same quarter last year, the firm earned $0.94 earnings per share. The company's revenue was up 1.4% on a year-over-year basis. On average, sell-side analysts expect that Plexus Corp. will post 5.9 earnings per share for the current year.

Wall Street Analyst Weigh In

PLXS has been the subject of several research reports. Benchmark reaffirmed a "buy" rating and set a $160.00 price target on shares of Plexus in a research note on Wednesday, June 4th. Wall Street Zen raised shares of Plexus from a "buy" rating to a "strong-buy" rating in a research note on Monday, June 30th. Stifel Nicolaus set a $145.00 price objective on Plexus in a report on Thursday, April 24th. Finally, Needham & Company LLC reissued a "buy" rating and issued a $162.00 target price (down from $172.00) on shares of Plexus in a research note on Friday, April 25th. Two research analysts have rated the stock with a hold rating, two have given a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $155.67.

Insider Transactions at Plexus

In other news, Director Karen Marie Rapp sold 500 shares of the business's stock in a transaction dated Friday, May 30th. The stock was sold at an average price of $130.77, for a total transaction of $65,385.00. Following the sale, the director directly owned 9,365 shares in the company, valued at approximately $1,224,661.05. The trade was a 5.07% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, CFO Patrick John Jermain sold 4,328 shares of the business's stock in a transaction dated Thursday, May 15th. The stock was sold at an average price of $132.29, for a total value of $572,551.12. Following the sale, the chief financial officer owned 25,637 shares in the company, valued at approximately $3,391,518.73. This trade represents a 14.44% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 12,032 shares of company stock valued at $1,582,222. Company insiders own 1.76% of the company's stock.

Plexus Profile

Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.